Budget expectations from Vikram Vuppala Founder and CEO, NephroPlus

▴ Vikram Vuppala Founder and CEO, NephroPlus
Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem

"As the government prepares for the 2025 Budget, we hope for a significant increase in funding to expand dialysis services under the PMNDP, addressing the urgent need for dialysis care across the country. Only 15% of patients who require dialysis get access currently. With Lakhs of new patients requiring regular dialysis, increasing dialysis care outlay and thereby increasing access to life sustaining care is crucial.  

Additionally, to position India as a global leader in healthcare in line with Vishwaguru philosophy, we urge the government to introduce tax incentives for healthcare services exports and provide robust support for R&D in innovative healthcare services. This will not only benefit millions of patients but also boost India’s stature in the global healthcare ecosystem" - Vikram Vuppala Founder and CEO, NephroPlus

 

About Vikram Vuppala Founder and CEO, NephroPlus (https://nephroplus.com/)

 

Vikram Vuppala is the Founder & CEO of India’s largest dialysis network - NephroPlus. After spending 10 years in the US healthcare industry, his passion for redefining healthcare delivery in India prompted him to launch NephroPlus in 2010. Today, NephroPlus has expanded to 400+ dialysis clinics in more than 230+ cities across 4 countries. It has rapidly grown under Vikram’s leadership to become the Asia's leading dialysis network.

 

He had raised a Series A Private equity investment of $4.3 MM from Bessemer Venture Partners (BVP) in Nov 2011, a Series B investment of $10 MM in May 2014 from IFC (World Bank arm) and BVP, and a Series C investment of $15 MM in Aug 2016 from IFC and SeaLink Capital. And recently, NephroPlus has secured INR 860 Crores in the Series F round, from Quadria Capital, a Singapore based healthcare-focused private equity firm.

 

Prior to founding NephroPlus, Vikram was a strategy consultant at McKinsey in the US. Vikram with over 18 years of global healthcare experience has helped hospitals, chains of clinics, healthcare distributors, and pharmaceutical clients on various strategic issues such as business development, growth strategy, portfolio rationalisation, and M&A. He has been a speaker at numerous entrepreneurial, healthcare and investment conferences. Vikram did his B. Tech. from IIT-Kharagpur and a full-time MBA from Chicago Booth

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026